H.U. Group Holdings, Inc. (TYO:4544)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Clinical Test Drugs Business	64.99B	64.97B	67.52B	77.67B	74.17B
Clinical Test Drugs Business Growth	0.03%	-3.77%	-13.07%	4.71%	31.79%
Healthcare Related Service	29.45B	29.57B	28.32B	27.77B	28.70B
Healthcare Related Service Growth	-0.38%	4.41%	1.96%	-3.23%	-
Unallocated Adjustment	-4.69B	-5.00B	-5.87B	-7.92B	-10.17B
Inspection and Related Service	157.61B	153.49B	146.99B	163.39B	180.24B
Inspection and Related Service Growth	2.68%	4.42%	-10.04%	-9.35%	-
Total	247.36B	243.03B	236.95B	260.91B	272.94B
Total Growth	1.78%	2.56%	-9.18%	-4.41%	22.39%

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
United States of America	12.19B	9.14B	7.60B	6.65B	6.69B
United States of America Growth	33.33%	20.30%	14.27%	-0.51%	0.18%
Others	9.20B	11.33B	11.80B	9.49B	7.81B
Others Growth	-18.75%	-4.01%	24.27%	21.61%	7.37%
Europe	17.82B	16.34B	15.52B	15.17B	14.76B
Europe Growth	9.03%	5.31%	2.32%	2.78%	22.69%
Japan	208.15B	206.22B	202.03B	229.60B	243.70B
Japan Growth	0.94%	2.07%	-12.01%	-5.79%	23.67%
Total	247.36B	243.02B	236.95B	260.91B	272.94B
Total Growth	1.78%	2.56%	-9.18%	-4.41%	22.39%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 25, 2026

Data Sources Report a data error